Preventing HIV Transmission in Africa - What We Need To Do in the Next Five Years
We are pleased to feature Dr. Catherine Hankins, the Scientific Chair of the INTEREST Conferences from 2014-2020, in the Online Meeting Highlights edition on HIV in Africa. Dr. Hankins draws from her rich expertise and summarizes how prevention remains an important pillar in bringing the HIV epidemic to an end in Sub-Saharan Africa, and what steps need to be taken in the coming years.
Ending AIDS as a Public Health Threat
The ambitious target of having achieved viral suppression in 73% of all people living with HIV by 2020, as set by the United Nations General Assembly in the Sustainable Development goals, has not yet been reached though a progressive increase can be observed globally. In Sub-Saharan Africa, gender and regional inequity remains with respect to prevalence, testing, mortality, and new infections.
Key Scientific Advances in HIV Prevention
Looking into the HIV treatment and prevention toolkit, data from recent and ongoing clinical trials show promising results for vaginal rings, oral PrEP, long-acting injectables, monoclonal antibodies, and preventive HIV vaccines.
What Is Needed Now
To bend the epidemic's trajectory further in Africa, the effects of the COVID-19 pandemic on HIV treatment and prevention services have to be addressed, as well as stigma which is an important impediment to rolling out programs and for people to come forward and participate. Finally, learn what is necessary to initiate comprehensive prevention programs that address the social determinants of HIV risk.
For more information on the module visit - https://academicmedicaleducation.com/online-meeting-highlights/2020-12?utm_source=newsletter&utm_medium=email&utm_campaign=OMH2403&utm_campaign=website&utm_source=sendgrid.com&utm_medium=email
Articles
Edctp Fellow Awarded Wellcome Leap Grant For Tb Research
EDCTP Career Development Fellow Dr Virginie Rozot, a research officer at the South African Tuberculosis Vaccine Initiative (SATVI), has been awarded a multi‑year contract under Wellcome Leap’s Delta Tissue (∆T) programme. Her research will investigate how the human immune system responds to Mycobacterium tuberculosis in the thoracic lymph nodes, and why these responses sometimes fail, allowing the bacteria to spread to other organs. The findings are expected to inform future TB vaccine design and vaccination strategies.
Applications Are Now Open For The Edctp Prizes 2027
Global Health EDCTP3 is now inviting applications for the EDCTP Prizes 2027, recognising outstanding individuals and research teams from Africa and Europe for their achievements in global health research and innovation.
The 2027 edition will award four prize categories, highlighting excellence in scientific leadership, collaborative team research, and gender-balanced scientific contributions. Prize winners will be announced at the EDCTP Forum 2027 in Madrid, Spain. Submissions are open until 2 September 2026.
Edctp Forum 2027: Calls For Abstracts, Scientific Symposia And Workshops Now Open
Global Health EDCTP3 has opened the calls for abstracts, scientific symposia and workshops for the EDCTP Forum 2027, one of the leading global health research events focused on infectious diseases in sub-Saharan Africa. The deadline for submissions is 2 September 2026 at 17:00 (Brussels time).
Under the theme ‘Innovating together for resilient global health', the 13th edition of the EDCTP Forum, taking place from 5-9 April 2027 in Madrid, Spain, will offer researchers, policymakers, funders and implementers the opportunity to showcase their work at a flagship global health event.
The Forum offers a unique platform to share research findings, build partnerships and help shape discussions on global health priorities. Currently, submissions for abstracts, scientific symposia and workshops are open.